Tablet . Scabo 12 mg (30 pcs )

Scabo tablet is indicated for the treatment of-

• Strongyloidiasis
• Onchocerciasis
• Filariasis
• Scabies &
• Head lice.

Strongyloidiasis of the intestinal tract: Scabo is indicated for the treatment of intestinal (i.e., nondisseminated) strongyloidiasis due to the nematode parasite Strongyloides stercoralis. This indication is based on clinical studies of both comparative and open-label designs, in which 64-100% of infected patients were cured following a single 200-mcg/kg dose of Scabo.

Onchocerciasis: Scabo is indicated for the treatment of onchocerciasis due to the nematode parasite Onchocerca volvulus. This indication is based on randomized, double-blind, placebo-controlled and comparative studies conducted in 1427 patients in onchocerciasis-endemic areas of West Africa. The comparative studies used diethylcarbamazine citrate (DEC-C).